NQL

System, Test, Amino Acids, Free Carnitines And Acylcarnitines Tandem Mass Spectrometry

Product code
NQL
Device name
System, Test, Amino Acids, Free Carnitines And Acylcarnitines Tandem Mass Spectrometry
Device class
Class 2
21 CFR
21 CFR 862.1055
Medical specialty
Clinical Chemistry
Marketing pathway
510(K)
510(k) clearances (all years, FDA)
5 (all years; only the last 3 years are listed here)

FDA classification definition

Amino acids, free carnitines and acylcarnitines test system is intended for the measurement and evaluation of amino acid, free carnitine and acylcarnitine concentrations from newborn whole blood filter paper samples. The quantitative analysis of the amino acids, free carnitines and acylcarnitines and their relationship with each other is intended to provide analyte concentration profiles that should aid in identifying elevated levels of these metabolites for screening newborns for one or more of several metabolic disorders.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: NQL
Classification and pathway per current FDA publications. Data from openFDA (CC0).